Evidence map›Paper›PMID 23226600›Full record

ReviewOpen biology2012

Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity.

Martina Beyrau, Jennifer Victoria Bodkin, Sussan Nourshargh

Registry-linked trialAbstract readReview
In one paragraph

Review in Open biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03479138 (Non-Eosinophilic Neutrophilic Asthma), which is not on this map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03479138 completednot on this mapstarted 2018, after this paper: background citation

Non-Eosinophilic Neutrophilic Asthma

TypeobservationalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2018 to 2023Enrolled10ConditionsNeutrophilic AsthmaArmsInduced sputum
3 · Its place in the literature

Who cites it

127 citing papers in PubMed.

  1. Trial
  2. Impact of intravitreal bevacizumab on immune cells in neovascular age related macular degeneration.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Flowers and Leaves ofPlants (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. The roles of neutrophils in cardiovascular diseases.Frontiers in cardiovascular medicine · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Neutrophil nucleus: shaping the past and the future.Journal of leukocyte biology · 2023
    Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martina BeyrauWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Jennifer Victoria Bodkin
Sussan Nourshargh

Funding

Wellcome Trust 098291/Z/12/Z
6 · The paper itself

Abstract

Leucocytes form the principal cellular components of immunity and inflammation, existing as multiple subsets defined by distinct phenotypic and functional profiles. To date, this has most notably been documented for lymphocytes and monocytes. In contrast, as neutrophils are traditionally considered, to be short-lived, terminally differentiated cells that do not re-circulate, the potential existence of distinct neutrophil subsets with functional and phenotypic heterogeneity has not been widely considered or explored. A growing body of evidence is now challenging this scenario, and there is significant evidence for the existence of different neutrophil subsets under both physiological and pathological conditions. This review will summarize the key findings that have triggered a renewed interest in neutrophil phenotypic changes, both in terms of functional implications and consequences within disease models. Special emphasis will be placed on the potential pro- and anti-inflammatory roles of neutrophil subsets, as indicated by the recent works in models of ischaemia-reperfusion injury, trauma, cancer and sepsis.

Indexed as

AnimalsBiomarkersCell DifferentiationCell LineageHumansImmunityInflammationIntercellular Signaling Peptides and ProteinsNeoplasmsNeutrophilsOrgan SpecificityReperfusion InjurySepsisBiomarkersIntercellular Signaling Peptides and Proteinsinflammationneutrophilneutrophil phenotypeneutrophil plasticityneutrophil subset

Identifiers

PMID23226600
PMCPMC3513838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.